Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.

Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a new release of the page template or platform updates. This appears to be a maintenance update rather than a modification to the study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now reflects a new revision label (v3.6.5) for the ClinicalTrials.gov interface, indicating an internal update rather than any change to the study information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows Revision: v3.6.4, replacing v3.6.3, indicating a minor platform update. This update does not change the study content or how essential information is displayed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing Revision: v3.6.2. This reflects an update to the page's underlying build or template rather than user-facing content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s revision label was updated to v3.6.2, replacing the previous v3.6.0. This indicates a newer release of the document or component reflected on the page.SummaryDifference0.1%

- Check86 days agoChange DetectedNew help and navigation sections were added to the study page, including How to Read a Study Record, Common Questions, and How to Join a Study, along with a clear note that recruitment is no longer ongoing. The page revision indicator was updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.